UnitedHealth Group (NYSE:UNH – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 29.500-30.000 for the period, compared to the consensus EPS estimate of 29.860. The company issued revenue guidance of $450.0 billion-$455.0 billion, compared to the consensus revenue estimate of $445.6 billion.
UnitedHealth Group Trading Up 1.8 %
Shares of UNH stock opened at $528.94 on Friday. The firm has a 50-day moving average price of $543.52 and a 200 day moving average price of $563.78. UnitedHealth Group has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market capitalization of $486.77 billion, a P/E ratio of 34.12, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the company posted $5.83 EPS. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group will post 29.74 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
Analysts Set New Price Targets
Several research firms have weighed in on UNH. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Morgan Stanley lowered their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $627.74.
View Our Latest Analysis on UnitedHealth Group
Insiders Place Their Bets
In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.33% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Industrial Products Stocks Investing
- Procter & Gamble Proves It’s No Gamble: Uptrend Remains Strong
- How to Use the MarketBeat Excel Dividend Calculator
- Should You Buy the Oil Dip? Top Energy Stocks to Hold Now
- Golden Cross Stocks: Pattern, Examples and Charts
- Market Momentum: 3 Stocks Poised for Significant Breakouts
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.